首页> 外文期刊>Neuroscience Letters: An International Multidisciplinary Journal Devoted to the Rapid Publication of Basic Research in the Brain Sciences >Inhibition of histone deacetylases enhances the function of serotoninergic neurons in organotypic raphe slice cultures
【24h】

Inhibition of histone deacetylases enhances the function of serotoninergic neurons in organotypic raphe slice cultures

机译:组蛋白脱乙酰酶的抑制增强了血清酮霉素在有机型raphe切片培养中的功能

获取原文
获取原文并翻译 | 示例
           

摘要

Inhibition of histone deacetylases (HDACs) is a promising approach for the treatment of mood disorders. However, the effects of HDAC inhibition on the serotonin (5-HT) system, a common target for psychiatric disorders, are poorly understood. Here, we show that a broad-spectrum HDAC inhibitor, trichostatin A (TSA), enhances the function of 5-HT neurons in organotypic raphe slice cultures. Sustained treatment with TSA (1 u,M) for 2 or 4 days significantly increased the 5-HT tissue content and tryptophan hydroxy-lase 2 (TPH2) expression, which were accompanied by hyper-acetylation of histone H3 in the promoter region of the TPH2 gene. TSA treatment for 4 days increased the extracellular 5-HT level, which was significantly suppressed in the presence of the selective AMPA receptor (AMPAR) antagonist NBQX. Moreover, the expression of both the AMPAR subunit GluA2 and Ca2+/calmodulin-dependent kinase II a (CaMKIIalpha) mRNAs were significantly increased by TSA treatment. Co-treatment with the CaMKII inhibitors KN-62 and KN-93 prevented the TSA-induced increase in 5-HT release, but had no effect on the increases in 5-HT tissue content. These results suggest that inhibition of HDACs increases 5-HT synthesis and release by epigenetic mechanisms, and that 5-HT release is mediated by the enhancement of AMPAR-mediated excitatory inputs and CaMKII signaling.
机译:组蛋白脱乙酰酶(HDACs)的抑制是治疗情绪障碍的有希望的方法。然而,HDAC抑制对血清素(5-HT)系统,精神疾病的常见目标的影响很差。在这里,我们表明广谱HDAC抑制剂Trichostatin A(TSA)增强了有机型Raphe培养物中5-Ht神经元的功能。用TSA(1 U,M)进行2或4天的持续处理显着增加了5-HT组织含量和色氨酸羟基液体2(TPH2)表达,其伴随着在启动子区中的组蛋白H3的超乙酰化TPH2基因。 TSA治疗4天增加了细胞外5-HT水平,在选择性AMPA受体(AMPAR)拮抗剂NBQx存在下显着抑制。此外,通过TSA治疗显着增加了AMPAR亚基GLUA2和CA2 + /钙调霉素依赖性激酶II A(Camkialpha)MRNA的表达。用Camkii抑制剂KN-62和KN-93进行共同处理,防止了TSA诱导的5-HT释放的增加,但对5-HT组织含量的增加没有影响。这些结果表明,HDAC的抑制增加了5-HT合成和通过表观遗传机制释放,并且通过增强Ampar介导的兴奋输入和Camkii信号传导来介导5-HT释放。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号